Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Homo sapiens | TEK tyrosine kinase, endothelial | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Tyrosine kinase homolog | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Onchocerca volvulus | Get druggable targets OG5_130320 | All targets in OG5_130320 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Tyrosine kinase homolog | 0.0172 | 0.9305 | 1 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0102 | 0.5273 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0102 | 0.5273 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0019 | 0.0484 | 0.0917 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0187 | 0.0354 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 1 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0102 | 0.5273 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0016 | 0.0272 | 0.0272 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Schistosoma mansoni | vesicular amine transporter | 0.0011 | 0.0021 | 0.004 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.0021 | 0.004 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.9006 | 0.9259 | |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0233 | 0.0233 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.0021 | 0.004 |
Echinococcus granulosus | roundabout 2 | 0.0022 | 0.065 | 0.1232 |
Echinococcus granulosus | twitchin | 0.0014 | 0.0187 | 0.0354 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0102 | 0.5273 | 0.5 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0184 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0399 | 0.0399 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0399 | 0.0399 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0233 | 0.0441 |
Plasmodium vivax | RNA helicase-1, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0187 | 0.0354 |
Echinococcus multilocularis | roundabout 2 | 0.0022 | 0.065 | 0.1232 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 0.5273 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0102 | 0.5273 | 1 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.0021 | 0.004 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.0021 | 0.004 |
Schistosoma mansoni | nephrin | 0.0018 | 0.0438 | 0.083 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0102 | 0.5273 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0102 | 0.5273 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0016 | 0.0272 | 0.0272 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.5273 | 0.5273 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA | ChEMBL. | 17676829 | |
IC50 (binding) | 0 | Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA | ChEMBL. | 17676829 |
IC50 (binding) | = 3200 nM | Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 3200 nM | Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 4000 nM | Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 4000 nM | Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus | ChEMBL. | 17676829 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.